Abstract:Abstract Abstract 4672 T-cell acute lymphoblastic leukemia (T-ALL) comprises 25% of adult acute lymphoblastic leukemia cases, and its outcome is poorly understood. To improve the outcome of patients with T-cell acute lymphoblastic leukemia (T-ALL), characterization of the biological features of T-ALL blast cells and the immune status of patients with T-ALL is needed to identify specific therapeutic strategies. Using a novel approach that is based on the combination of fine-tiling comparative genomic hybridization (FT-CGH) and ligation mediated PCR (LM-PCR), we molecularly identified a malignant ¦Ã¦Ä+T cell clone with a V¦Ä5D¦Ä2J¦Ä1 rearrangement that was paired with a V¦ÃI TCR and comprised a V¦Ã1V¦Ä5 T cell clone in relapse T-ALL patient. This malignant T cell clone was lost after chemotherapy, while the same malignant V¦Ä5 T cell clone revealed when disease relapse post allo-HSCT at 100 weeks (Figure 1). Using PCR and genescan analyses, the distribution and clonality of the TCRV¦Ã and TCRV¦Ä subfamilies were examined before and after allo-HSCT in a patient with T-ALL. A reactive T cell clone with a V¦Ä4D¦Ä3J¦Ä1 rearrangement was identified in all samples taken at different time points (i.e., 4, 8, 68, 100 and 108 weeks after allo-HSCT) (Figure 2). The expression of this V¦Ä4+ T cell clone was higher in the patient during complete remission post allo-SCT, and at disease relapse. In conclusion, the techniques used in this study established the sensitive detection of malignant and reactive T cell clones, and these identified T cell clones may serve not only as biomarkers for minimal residual disease detection but also as indicators for the anti-leukemia immune status in patients who achieve CR. Fig. 1. The clonality and size of V¦Ä5 T cells from a patient with T-ALL at different time points before and after allo-HSCT. A: T-ALL relapse before allo-HSCT. The monoclonal V¦Ä5 product size was 466 bp; B: pre-HSCT; C: 4 weeks post allo-HSCT; D: 8 weeks post allo-HSCT; E: 68 weeks post allo-HSCT. The clonal V¦Ä5 products were 459 and 477 bp. F: 100 weeks post allo-HSCT and disease relapse and G: 108 weeks post allo-HSCT and after one chemotherapy cycle. The same 466 bp monoclonal V¦Ä5 product is observed. The right figure demonstrates the expression level of the monoclonal V¦Ä5 gene at different time points. Fig. 1. The clonality and size of V¦Ä5 T cells from a patient with T-ALL at different time points before and after allo-HSCT. A: T-ALL relapse before allo-HSCT. The monoclonal V¦Ä5 product size was 466 bp; B: pre-HSCT; C: 4 weeks post allo-HSCT; D: 8 weeks post allo-HSCT; E: 68 weeks post allo-HSCT. The clonal V¦Ä5 products were 459 and 477 bp. F: 100 weeks post allo-HSCT and disease relapse and G: 108 weeks post allo-HSCT and after one chemotherapy cycle. The same 466 bp monoclonal V¦Ä5 product is observed. The right figure demonstrates the expression level of the monoclonal V¦Ä5 gene at different time points. Fig. 2. The V¦Ä4 gene expression level at different time points post allo-HSCT. *The study was supported by grants from the National Natural Science Foundation of China (No. 30871091 and 91129720) and the Fundamental Research Funds for the Central Universities (No. 21610603 and 21612116) and the Guangdong Science & Technology Project (No. 2012B050600023). Fig. 2. The V¦Ä4 gene expression level at different time points post allo-HSCT. . / *The study was supported by grants from the National Natural Science Foundation of China (No. 30871091 and 91129720) and the Fundamental Research Funds for the Central Universities (No. 21610603 and 21612116) and the Guangdong Science & Technology Project (No. 2012B050600023). Disclosures: Chen: The study was supported by grants from the National Natural Science Foundation of China (No. 30871091 and 91129720) and the Fundamental Research Funds for the Central Universities (No. 21610603 and 21612116) and the Guangdong Science & Technology Project: Research Funding. Huang:The study was supported by grants from the National Natural Science Foundation of China (No. 30871091 and 91129720) and the Fundamental Research Funds for the Central Universities (No. 21610603 and 21612116) and the Guangdong Science & Technology Project: Research Funding. Zheng:The study was supported by grants from the National Natural Science Foundation of China (No. 30871091 and 91129720) and the Fundamental Research Funds for the Central Universities (No. 21610603 and 21612116) and the Guangdong Science & Technology Project: Research Funding. Geng:The study was supported by grants from the National Natural Science Foundation of China (No. 30871091 and 91129720) and the Fundamental Research Funds for the Central Universities (No. 21610603 and 21612116) and the Guangdong Science & Technology Project: Research Funding. Hu:The study was supported by grants from the National Natural Science Foundation of China (No. 30871091 and 91129720) and the Fundamental Research Funds for the Central Universities (No. 21610603 and 21612116) and the Guangdong Science & Technology Project: Research Funding. Zhang:The study was supported by grants from the National Natural Science Foundation of China (No. 30871091 and 91129720) and the Fundamental Research Funds for the Central Universities (No. 21610603 and 21612116) and the Guangdong Science & Technology Project: Research Funding. Yang:The study was supported by grants from the National Natural Science Foundation of China (No. 30871091 and 91129720) and the Fundamental Research Funds for the Central Universities (No. 21610603 and 21612116) and the Guangdong Science & Technology Project: Research Funding. Weng:The study was supported by grants from the National Natural Science Foundation of China (No. 30871091 and 91129720) and the Fundamental Research Funds for the Central Universities (No. 21610603 and 21612116) and the Guangdong Science & Technology Project: Research Funding. Du:The study was supported by grants from the National Natural Science Foundation of China (No. 30871091 and 91129720) and the Fundamental Research Funds for the Central Universities (No. 21610603 and 21612116) and the Guangdong Science & Technology Project: Research Funding. Li:The study was supported by grants from the National Natural Science Foundation of China (No. 30871091 and 91129720) and the Fundamental Research Funds for the Central Universities (No. 21610603 and 21612116) and the Guangdong Science & Technology Project: Research Funding.

Single‐Cell Multiomics Reveals TCR Clonotype‐Specific Phenotype and Stemness Heterogeneity of T‐ALL Cells

Transcriptome-wide subtyping of pediatric and adult T cell acute lymphoblastic leukemia in an international study of 707 cases

UTX Inhibition As Selective Epigenetic Therapy Against TAL1-driven T-cell Acute Lymphoblastic Leukemia

Clonal Evolution Dissection Reveals High MSI2 Level Promotes Chemo-resistance in T-cell Acute Lymphoblastic Leukemia

Decoding Clonal Evolution in Relapsed T Cell Acute Lymphoblastic Leukemia at Single Cell Resolution

Single-cell Profiling of T Cells Uncovers a Tissue-Resident Memory-Like T-cell Subset Associated with Bidirectional Prognosis for B-cell Acute Lymphoblastic Leukemia

Single-cell sequencing technology to characterize stem T-cell subpopulations in acute T-lymphoblastic leukemia and the role of stem T-cells in the disease process

Multi-omics integration reveals potential stage-specific druggable targets in T-cell acute lymphoblastic leukemia

Single‐Cell RNA‐Seq of T Cells in B‐ALL Patients Reveals an Exhausted Subset with Remarkable Heterogeneity

Single-cell CRISPR screening characterizes transcriptional deregulation in Tcell acute lymphoblastic leukemia

Clonal Evolution Dissection Reveals That a High MSI2 Level Promotes Chemoresistance in T-cell Acute Lymphoblastic Leukemia.

Role of Stem-Like Cells in Chemotherapy Resistance and Relapse in pediatric T Cell Acute Lymphoblastic Leukemia

Single-cell sequencing unveils T-cell characteristic in acute myeloid leukemia

Identification and targeting of treatment resistant progenitor populations in T-cell Acute Lymphoblastic Leukemia

The genomic basis of childhood T-lineage acute lymphoblastic leukaemia

Persistent Clonal Expansion of Vδ3 and Vδ4 T Cells in T-ALL Case with Minimal Residual Disease after HSCT

The TCR Γδ Repertoire and Relative Gene Expression Characteristics of T-ALL Cases with Biclonal Malignant Vδ1 and Vδ2 T Cells.

The Evolution of Malignant and Reactive γδ+T Cell Clones in Relapse T-ALL After Allogeneic Stem Cell Transplantation

Identification of Novel Fusion Genes and Characterization of Transcriptome Features in T-Cell Acute Lymphoblastic Leukemia

Identification of Fusion Genes and Characterization of Transcriptome Features in T-cell Acute Lymphoblastic Leukemia.

118 Single-cell Transcriptomics Links Cellular Origins of Malignant T Cells to the Tumor Immune Landscape in Cutaneous T Cell Lymphoma